Tag: coagulation

March 1, 2018

Catalyst Biosciences Reports Fourth Quarter and Full-Year 2017 Operating & Financial Results

Catalyst Biosciences (NASDAQ:CBIO) announced operating and financial results for the fourth quarter and full-year ended December 31, 2017 and provided...
February 26, 2018

Catalyst Biosciences Announces Manufacturing Agreement with AGC Biologics

Catalyst Biosciences (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced that they...
February 9, 2018

Catalyst Biosciences Announces Positive Top-Line Data from Phase 1/2 Study of Subcutaneous CB

Catalyst Biosciences (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced top-line data...
November 16, 2017

Titan Medical Gives Updates on Medical Center Use of Sport Surgical System

Titan Medical shared an update on the surgical simulation center at the Columbia University Medical Center using the company's SPORT...
April 20, 2017

Lithium Carbonate Purity Results Are In, Enertopia Announces 2nd Phase Testing

Enertopia Corporation (CNSX:TOP; OTCQB:ENRT)  (the “Company” or “Enertopia”) is pleased to announce the lithium carbonate purity results from Avomeen Analytical Services....
April 10, 2017

Aptevo Shows New Clinical Data For IXINITY

Aptevo Therapeutics (NASDAQ:APVO) presented new clinical data on the safety and efficacy fo IXINITY, in previously treated patients.
April 7, 2017

Catalyst Announces Pricing of $18 Million Public Offering

Catalyst Biosciences revealed the price for its upcoming $18 million public offering.